Vis enkel innførsel

Use of Selective Serotonin Reuptake Inhibitors – Validity of Self-Report versus Plasma Concentrations and Pharmacy Dispensations – A Cross-Sectional Analysis of the Norwegian Women and Cancer Study

dc.contributor.authorWaaseth, Marit
dc.contributor.authorHavelkova, Martina
dc.contributor.authorForsdahl, Guro
dc.contributor.authorLund, Eiliv
dc.contributor.authorLog, Tomas
dc.date.accessioned2022-11-10T12:43:03Z
dc.date.available2022-11-10T12:43:03Z
dc.date.created2022-08-10T13:32:35Z
dc.date.issued2022
dc.identifier.citationWaaseth, M., Havelkova, M., Forsdahl, G., Lund, E. & Log, T. (2022). Use of selective serotonin reuptake inhibitors – Validity of self-report versus plasma concentrations and pharmacy dispensations – A cross-sectional analysis of the Norwegian women and cancer study. Clinical Epidemiology, 14, 815-826. doi:en_US
dc.identifier.issn1179-1349
dc.identifier.urihttps://hdl.handle.net/11250/3031206
dc.language.isoengen_US
dc.publisherDove Medical Press Ltd.en_US
dc.rightsNavngivelse-Ikkekommersiell 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/deed.no*
dc.titleUse of Selective Serotonin Reuptake Inhibitors – Validity of Self-Report versus Plasma Concentrations and Pharmacy Dispensations – A Cross-Sectional Analysis of the Norwegian Women and Cancer Studyen_US
dc.title.alternativeUse of Selective Serotonin Reuptake Inhibitors – Validity of Self-Report versus Plasma Concentrations and Pharmacy Dispensations – A Cross-Sectional Analysis of the Norwegian Women and Cancer Studyen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.rights.holder© 2022 The Authorsen_US
dc.subject.nsiVDP::Medisinske Fag: 700::Helsefag: 800::Samfunnsfarmasi: 812en_US
dc.subject.nsiVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Psykiatri, barnepsykiatri: 757en_US
dc.subject.nsiVDP::Samfunnsvitenskap: 200::Kvinne- og kjønnsstudier: 370en_US
dc.subject.nsiVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Onkologi: 762en_US
dc.source.pagenumber815-826en_US
dc.source.volume14en_US
dc.source.journalClinical Epidemiologyen_US
dc.identifier.doi10.2147/clep.S366760
dc.identifier.cristin2042222
dc.relation.projectNorthern Norway Regional Health Authority: 7075/PFP1077-12en_US


Tilhørende fil(er)

Thumbnail
Filnavn:
Waaseth.pdf
Størrelse:
1.533Mb
Format:
PDF
Åpne

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse-Ikkekommersiell 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse-Ikkekommersiell 4.0 Internasjonal